EUROPEAN RESEARCH AND PREPAREDNESS NETWORK FOR PANDEMICS AND EMERGING INFECTIOUS DISEASES
EU-RESPONSE is funded by the European Union’s Horizon 2020 research and innovation programme.
EU-RESPONSE is a 5-year project that includes two broad European Adaptive Platform Trials, DisCoVeRy and EU-SolidAct. The EU-RESPONSE consortium is composed of 22 partners, bringing together multidisciplinary partners from across the continent.
22
Partners
16
Countries
Survey: Databases for Target Trial Emulations
Identify high-quality databases of hospitalized respiratory infectious disease patients.
Latest results of the EU-SolidAct Adaptive Platform Trial
Baricitinib as a Treatment for Hospitalized COVID-19 Patients Published in Critical Care Journal